Drugs / plain polisacaride vaccine 23 valent
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00580684 | Sep 2003 → Aug 2004 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plain polisacaride vaccine 23 valent | “plain polisacaride vaccine 23 valent to reduce carriage” NCT00580684 ↗ |
| Modality | Vaccine | “plain polisacaride vaccine 23 valent to reduce carriage” NCT00580684 ↗ |